Are You Looking for a Top Momentum Pick? Why Eli Lilly (LLY) is a Great Choice

Core Viewpoint - Momentum investing focuses on following a stock's recent price trends, aiming to buy high and sell higher, with the expectation that established trends will continue [1] Company Overview: Eli Lilly (LLY) - Eli Lilly currently holds a Momentum Style Score of B and a Zacks Rank of 1 (Strong Buy), indicating strong potential for outperformance [2][3] - The stock has shown a price increase of 0.24% over the past week, while the Zacks Large Cap Pharmaceuticals industry has decreased by 0.13% during the same period [5] - Over the last quarter, Eli Lilly's shares have increased by 27.11%, and over the past year, they have gained 36.13%, significantly outperforming the S&P 500, which moved 3.09% and 17.53% respectively [6] Trading Volume and Market Activity - Eli Lilly's average 20-day trading volume is 2,659,607 shares, which serves as a bullish indicator when combined with rising stock prices [7] Earnings Outlook - In the past two months, 3 earnings estimates for Eli Lilly have been revised upwards, while 2 have been revised downwards, leading to an increase in the consensus estimate from $23.60 to $23.78 [9] - For the next fiscal year, 8 estimates have moved upwards with no downward revisions, indicating positive sentiment regarding future earnings [9] Conclusion - Given the strong performance metrics and positive earnings outlook, Eli Lilly is positioned as a solid momentum pick and should be considered for investment [11]